1. Home
  2. LMNR vs VYGR Comparison

LMNR vs VYGR Comparison

Compare LMNR & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limoneira Co

LMNR

Limoneira Co

HOLD

Current Price

$12.69

Market Cap

233.9M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.75

Market Cap

227.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMNR
VYGR
Founded
1893
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.9M
227.2M
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
LMNR
VYGR
Price
$12.69
$3.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$20.00
$16.50
AVG Volume (30 Days)
53.7K
524.5K
Earning Date
06-08-2026
05-08-2026
Dividend Yield
2.37%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$159,723,000.00
$10,135,000.00
Revenue This Year
N/A
$34.04
Revenue Next Year
$13.95
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.20
$2.65
52 Week High
$17.11
$5.55

Technical Indicators

Market Signals
Indicator
LMNR
VYGR
Relative Strength Index (RSI) 43.03 46.11
Support Level $12.54 $3.71
Resistance Level $14.86 $4.39
Average True Range (ATR) 0.36 0.26
MACD -0.01 -0.03
Stochastic Oscillator 2.53 34.55

Price Performance

Historical Comparison
LMNR
VYGR

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: